Cytokines prevent dexamethasone-induced apoptosis via the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways in a new multiple myeloma cell line1

Cancer Research

Volumn 60, Issue 15, 2000, Pages 4262-4269

  Ogawa, M ^a   Nishiura, T ^a   Oritani, K ^a   Yoshida, H ^a   Yoshimura, M ^a   Okajima, Y ^a   Ishikawa, J ^a   Hashimoto, K ^a   Matsumura, I ^a   Tomiyama, Y ^a   Matsuzawa, Y ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ALPHA1 INTERFERON; CYTOKINE; DEXAMETHASONE; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL X; SOMATOMEDIN C; WORTMANNIN;

AGED; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CANCER CELL CULTURE; CASE REPORT; CHROMOSOME ANALYSIS; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MYELOMA CELL; PHENOTYPE; PLASMA CELL LEUKEMIA; PRIORITY JOURNAL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AGED; APOPTOSIS; CASPASE 3; CASPASES; DEXAMETHASONE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTERFERON TYPE I, RECOMBINANT; INTERLEUKIN-6; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MULTIPLE MYELOMA; RECEPTOR, IGF TYPE 1; RECEPTOR, INTERFERON ALPHA-BETA; RECEPTORS, INTERFERON; RECEPTORS, INTERLEUKIN-6; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0033887015     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Production of growth factors by human myeloma cells
2. Response patterns of purified myeloma cells to hematopoietic growth factors
3. Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130
4. Multiple myeloma: Increasing evidence for a multistep transformation process
5. The in vitro effect of leucocyte α-interferon on human myeloma cells in a semisolid agar culture system
6. IFN-α induces autocrine production of IL-6 in myeloma cell lines
7. Interleukin-6 in human multiple myeloma
8. Apoptosis by death factor
9. The Bcl-2 protein family: Arbiters of cell survival
10. Interleukin-6 inhibits apoptosis of malignant plasma cells
11. Multiple myeloma cells are protected against dexamethasone-induced apoptosis by insulin-like growth factors
12. Interleukin-6 inhibits Fas-induced apoptosis and stress-activated protein kinase activation in multiple myeloma cells
13. Modulation of Apo-1/Fas (CD95)-induced programmed cell death in myeloma cells by interferon-α2
14. Interleukin-6 prevents dexamethasone-induced myeloma cell death
15. Aberrant expression of immunoglobulin light chain isotype in B lymphocytes from patients with monoclonal gammopathies: Isotypic discordance and clonal B-cell excess
16. Induction of programmed cell death in human hematopoietic cell lines by fibronectin via its interaction with very late antigen 5
17. Functional role of cation-independent mannose 6-phosphate/insulin-like growth factor II receptor in cell adhesion and proliferation of a human myeloma cell line OPM-2
18. Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells
19. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V
20. Insulin-like growth factor I is a growth and survival factor in human multiple myeloma cell lines
21. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo
22. Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase
23. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas
24. Characterization of an interleukin-6-mediated autocrine growth loop in the human multiple myeloma cell line, U266
25. Insulin and IGF-1 increase mitogenesis and glucose metabolism in the multiple myeloma cell line, RPMI 8226
26. A role for insulin-like growth factor in the regulation of IL-6-responsive human myeloma cell line growth
27. Functional insulin and insulin-like growth factor-1 receptors are preferentially expressed in multiple myeloma cell lines as compared to B-lymphoblastoid cell lines
28. Mechanisms of glucocorticoid action on immune processes
29. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation
30. Cytotoxic T lymphocytes and glucocorticoids activate an endogenous suicide process in target cells
31. Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor
32. Suppression of c-myc is a critical step in glucocorticoid-induced human leukemic cell lysis
33. Mechanisms in interleukin-2 protection against glucocorticoid-induced apoptosis: Regulation of AP-1 and glucocorticoid receptor transcriptional activities
34. Glucocorticoid-induced apoptosis of lymphoid cells
35. Dexamethasone-induced thymocyte apoptosis: Apoptotic signal involves the sequential activation of phosphoinositide-specific phospholipase C, acidic sphingomyelinase, and caspases
36. Dexamethasone induces apoptosis of multiple myeloma cells in a JNK/SAP kinase independent mechanism
37. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor
38. Requirement for phosphatidylinositol 3'-kinase to protect hemopoiefic progenitors against apoptosis depends upon the extracellular survival factor
39. IFN-α is a survival factor for human myeloma cells and reduces dexamethasone-induced apoptosis
40. Interferon-α protects myeloma cell lines from dexamethasone-induced apoptosis
41. Effects of cloned human leukocyte interferons in the human tumor stem cell assay
42. Interferon-α down-regulates the interleukin-6 receptor in a human multiple myeloma cell line, U266
43. Disruption by interferon-α of an autocrine interleukin-6 growth loop in IL-6-dependent U266 myeloma cells by homologous and heterologous down-regulation of the IL-6 receptor α- and β-chains
44. Role of G0-G1 arrest in the inhibition of tumor cell growth by interferon
45. Maintenance treatment with recombinant interferon α-2b in patients with multiple myeloma responding to conventional induction chemotherapy
46. Health-related quality of life assessed before and during chemotherapy predicts for survival in multiple myeloma
47. Interferon α-2b versus no maintenance therapy during the plateau phase in multiple myeloma: A randomized study
48. Role of α interferon in multiple myeloma
49. Retinoic acid modulates the in vivo and in vitro growth of IL-6 autocrine human myeloma cell lines via induction of apoptosis
50. Inhibition of myeloma cell growth by dexamethasone and all-trans retinoic acid: Synergy through modulation of interleukin-6 autocrine loop at multiple sites
51. Effect of glucocorticoids on the biologic activities of myeloma cells: Inhibition of interleukin-1 β osteoclast activating factor-induced bone resorption
52. Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia
53. Anti-human interleukin-6 receptor antibody inhibits human myeloma growth in vivo
54. Reshaping a human antibody to inhibit the interleukin 6-dependent tumor cell growth
55. Epitope peptides from interleukin-6 receptor which inhibit the growth of human myeloma cells
56. IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade
57. Inhibitors of Ras farnesyltransferases